[Intestinal absorption, organ and tissue distribution of 3H labelled distigmine bromide (true cholinesterase inhibitor) in rats and mice].
D000284:Administration, Oral; D000818:Animals; D001345:Autoradiography; D001921:Brain / Q000378:metabolism; D002219:Carbamates / Q000008:administration & dosage / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism; D007273:Injections, Intramuscular; D007408:Intestinal Absorption; D007420:Intestine, Large / Q000378:metabolism; D007421:Intestine, Small / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D011726:Pyridinium Compounds / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats; D013154:Spleen / Q000378:metabolism; D014316:Tritium
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D011726:Pyridinium Compounds; D014316:Tritium